New funding to advance non-surgical brain interface technology and expand clinical and engineering capabilities globally
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
The partnership aligns with the launch of Oracle Health’s next-generation electronic health record
Enabling a new era in minimally invasive obesity treatment across Europe
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
Venus Remedies now has 29 active product approvals in Vietnam alone
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
The device delivers clear, high-quality images to support accurate diagnoses across a broad range of patient groups
Subscribe To Our Newsletter & Stay Updated
